Advertisement

Calbindin immunoreactive neurones in Alzheimer-type dementia

  • Y. Ichimiya
  • H. Arai
  • R. Iizuka
  • P. C. Emson
  • C. Q. Mountjoy
Part of the Key Topics in Brain Research book series (KEYTOPICS)

Summary

An antibody to the calcium binding protein, calbindin D28k (CaBP), was used to study the number and size of CaBP immunoreactive (CaBP-Ir) neurones in the cerebral cortex and the nucleus basalis of Meynert (nbM) of postmortem human brains from controls and from patients with Alzheimer-type dementia (ATD).

Compared to the controls, the number and size of CaBP-Ir neurones in the cerebral cortex and the nbM were reduced in the ATD.

These findings suggest that CaBP containing neurones are damaged in ATD.

Keywords

Nucleus Basalis Immunoreactive Neurone Postmortem Human Brain Normal Elderly Control ChAT Immunoreactivity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arai H, Emson PC, Mountjoy CQ, Carassco LH, Heizmann CW (1987) Loss of parvalbumin-immunoreactive neurones from cortex in Alzheimer-type dementia. Brain Res 418: 164–169PubMedCrossRefGoogle Scholar
  2. Campbell AK (1985) Intracellular calcium. John Wiley & Sons Ltd, Chichester New York Brisbane Toronto SingaporeGoogle Scholar
  3. Celio MR, Norman AW (1985) Nucleus basalis Meynert neurons contain the vitamin D-induced calcium-binding protein (calbindin-D 28k). Anat Embryol 173: 143–148PubMedCrossRefGoogle Scholar
  4. Cotman CW, Iversen LL (1987) Excitatory amino acids in the brain-focus on NMDA receptors. TINS 10: 263–272Google Scholar
  5. Heizmann CW, Berchtold MW (1987) Expression of parvalbumin and other Ca++ -binding proteins in normal and tumor cells: a topical review. Cell Calcium 8: 1–41PubMedCrossRefGoogle Scholar
  6. Ichimiya Y, Arai H, Kosaka K, Iizuka R (1986) Morphological and biochemical changes in the cholinergic and monoanimergic systems in Alzheimer-type dementia. Acta Neuropathol (Berl) 70: 112–116CrossRefGoogle Scholar
  7. Ichimiya Y, Emson PC, Mountjoy CQ, Lawson DEM, Heizmann CW (1988) Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain Res 475: 156–159PubMedCrossRefGoogle Scholar
  8. Ichimiya Y, Emson PC, Mountjoy CQ, Lawson DEM, Iizuka R (1989) Calbindin immunoreactive cholinergic neurones in the nucleus basalis of Meynert in Alzheimer-type dementia. Brain Res 499: 402–406PubMedCrossRefGoogle Scholar
  9. McLachlan DRC, Wong L, Bergeron C, Baimbridge KG (1987) Calmodulin and calbindin D28k in Alzheimer disease. Alzheimer Disease and Associated Disorders 1: 171–179PubMedCrossRefGoogle Scholar
  10. Mountjoy CQ, Roth M, Evans NJR, Evans HM (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging 4: 1–11PubMedCrossRefGoogle Scholar
  11. Nagai R, McGeer PL, Peng JH, McGeer EG, Dolman CE (1983) Choline acetyltransferase immunohistochemistry in brains of Alzheimer’s disease patients and controls. Neurosci Lett 36: 195–199PubMedCrossRefGoogle Scholar
  12. Parmentier M, Ghysels M, Rypens F, Lawson DEM, Pasteels JL, Pochet R (1987) Calbindin in vertebrate classes: immunohistochemical localization and Western blot analysis. Gen Comp Endocrinol 65: 399–407PubMedCrossRefGoogle Scholar
  13. Pochet R, Parmentier M, Lawson DEM, Pasteels JL (1985) Rat brain synthesizes two `vitamin D-dependent’ calcium-binding proteins. Brain Res 345: 251–256PubMedCrossRefGoogle Scholar
  14. Rothman SM, Olney JW (1987) Excitotoxicity and NMDA receptor. TINS 10: 299–302Google Scholar

Copyright information

© Springer-Verlag Wien 1990

Authors and Affiliations

  • Y. Ichimiya
    • 1
  • H. Arai
    • 1
  • R. Iizuka
    • 1
  • P. C. Emson
    • 2
  • C. Q. Mountjoy
    • 3
  1. 1.Department of PsychiatryJuntendo University School of MedicineTokyoJapan
  2. 2.MRC GroupInstitute of Animal Physiology and Genetics ResearchBabrahamUK
  3. 3.Department of PsychiatryUniversity of CambridgeCambridgeUK

Personalised recommendations